News
Helius Medical Technologies calls the out-of-network reimbursement the first step in making the PoNS device more accessible to MS patients.
MyChesCo on MSN10h
Helius Shares Positive PoNSTEP Study Results on PoNS Therapy for MSNEWTOWN, PA — Helius Medical Technologies, Inc. (NASDAQ: HSDT) announced encouraging results from its PoNSTEP study, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback